GM1-ELISAs using purified LTG33D and parenteral LT derived from ETEC H10407 strain were carried out as reported previously [40]. BALB/c Wnt inhibitor mice, 4–6 weeks old, were divided into groups (n = 6 for immune response monitoring and n = 10 for the virus challenges) and submitted to an immunization

regimen comprising four doses of the tested vaccine formulations administered via the subcutaneous (s.c.) route on days 0, 14, 21 and 28 ( Fig. 1). Mice were inoculated with 10 μg of NS1 alone or the same amount of NS1 combined with: 1.25 μg of alum (Rehydragel from Reheis), according to a standard procedure [46] that results in 99.7% binding of the protein to the solid matrix, Freund’s adjuvant (50%, v/v), with the complete adjuvant in the first

dose and the incomplete formulation in the subsequent injections; or 1 μg of LTG33D. The amount of LTG33D used in the vaccine formulations was based on previously reported results [36]. Sham-treated mice were injected with phosphate buffered saline (PBS). Mice were bled at the retro-orbital plexus before each vaccine dose and one week after the last administration. Serum samples were individually tested for reactivity to NS1, pooled and stored at −20 °C for subsequent analyses. Mouse sera were tested individually for the presence of Panobinostat purchase NS1-specific antibodies by ELISA, as previously described [45]. Briefly, MaxiSorp plates (Nunc) were coated with 0.2 μg per well of the recombinant NS1 protein in 100 μL PBS and blocked for 1 h at 37 °C with 5% skim milk in 0.05% Tween-20–PBS (PBST). Serum samples were serially diluted and added to wells previously washed with PBST. After 1 h at room temperature, plates were washed with PBST and incubated with goat anti-mouse

immunoglobulin (whole IgG isotype, IgG1 or IgG2a subclasses) conjugated with horseradish peroxidase Megestrol Acetate (Southern Biotechnology) for 1 h at room temperature. Reactions were measured at A490 nm with ortho-phenylenediamine dihydrochloride (Sigma) and H2O2 as substrate and with a 2 N H2SO4 stopping solution. Titers were established as the reciprocal of serum dilution which gave an absorbance two-fold higher than the SD values of the respective non-immunized samples. One week after the last immunization, mice were euthanized and their spleens were harvested. Splenocytes were pooled and seeded (5 × 105 cells per well) in 12-well plates (Nunc) in RPMI supplemented with 10% FBS, 2 mM l-glutamine, 1 mM sodium pyruvate, 2 mM nonessential amino acids, 10 mM HEPES buffer and 50 units/ml of penicillin–streptomycin. Cells were then incubated with purified NS1 at 37 °C with 5% CO2 for 48 h. Culture supernatants were collected and tested individually for IFN-γ and IL-5 by ELISA, according to the manufacturer’s instructions (BD Bioscience), as markers for activation of type 1 and type 2 Th responses, respectively.